| Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice T Hendrikx, YI Duan, Y Wang, JH Oh, LM Alexander, W Huang, P Stärkel, ... Gut 68 (8), 1504-1515, 2019 | 230 | 2019 |
| Synthesis and Ligand Binding of Nortropane Derivatives: N-Substituted 2β-Carbomethoxy-3β-(4‘-iodophenyl)nortropane and N-(3-Iodoprop-(2E)-enyl)-2β … P Emond, L Garreau, S Chalon, M Boazi, M Caillet, J Bricard, Y Frangin, ... Journal of medicinal chemistry 40 (9), 1366-1372, 1997 | 154 | 1997 |
| Visualization of the dopamine transporter in the human brain postmortem with the new selective ligand [125I] PE2I H Hall, C Halldin, D Guilloteau, S Chalon, P Emond, JC Besnard, L Farde, ... Neuroimage 9 (1), 108-116, 1999 | 144 | 1999 |
| 1H-NMR-Based Metabolomic Profiling of CSF in Early Amyotrophic Lateral Sclerosis H Blasco, P Corcia, C Moreau, S Veau, C Fournier, P Vourc'h, P Emond, ... PloS one 5 (10), e13223, 2010 | 141 | 2010 |
| GC-MS-based urine metabolic profiling of autism spectrum disorders P Emond, S Mavel, N Aïdoud, L Nadal-Desbarats, F Montigny, ... Analytical and bioanalytical chemistry 405, 5291-5300, 2013 | 121 | 2013 |
| [11C]PE2I: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain C Halldin, N Erixon-Lindroth, S Pauli, YH Chou, Y Okubo, P Karlsson, ... European journal of nuclear medicine and molecular imaging 30, 1220-1230, 2003 | 114* | 2003 |
| The specific metabolome profiling of patients infected by SARS-COV-2 supports the key role of tryptophan-nicotinamide pathway and cytosine metabolism H Blasco, C Bessy, L Plantier, A Lefevre, E Piver, L Bernard, J Marlet, ... Scientific reports 10 (1), 16824, 2020 | 108 | 2020 |
| Microbiota tryptophan metabolism induces aryl hydrocarbon receptor activation and improves alcohol-induced liver injury L Wrzosek, D Ciocan, C Hugot, M Spatz, M Dupeux, C Houron, ... Gut 70 (7), 1299-1308, 2021 | 104 | 2021 |
| Metabolomics study of urine in autism spectrum disorders using a multiplatform analytical methodology B Diémé, S Mavel, H Blasco, G Tripi, F Bonnet-Brilhault, J Malvy, C Bocca, ... Journal of proteome research 14 (12), 5273-5282, 2015 | 100 | 2015 |
| Metabolomics in cerebrospinal fluid of patients with amyotrophic lateral sclerosis: an untargeted approach via high-resolution mass spectrometry H Blasco, P Corcia, PF Pradat, C Bocca, PH Gordon, C Veyrat-Durebex, ... Journal of proteome research 12 (8), 3746-3754, 2013 | 100 | 2013 |
| Gut microbiota-stimulated innate lymphoid cells support β-defensin 14 expression in pancreatic endocrine cells, preventing autoimmune diabetes M Miani, J Le Naour, E Waeckel-Enée, S chand Verma, M Straube, ... Cell metabolism 28 (4), 557-572. e6, 2018 | 96 | 2018 |
| Comparative analysis of targeted metabolomics: dominance-based rough set approach versus orthogonal partial least square-discriminant analysis H Blasco, J Błaszczyński, JC Billaut, L Nadal-Desbarats, PF Pradat, ... Journal of Biomedical Informatics 53, 291-299, 2015 | 90 | 2015 |
| Exploration of the dopamine transporter: in vitro and in vivo characterization of a high-affinity and high-specificity iodinated tropane derivative (E)-N-(3-iodoprop-2-enyl)-2β … D Guilloteau, P Emond, JL Baulieu, L Garreau, Y Frangin, L Pourcelot, ... Nuclear medicine and biology 25 (4), 331-337, 1998 | 90 | 1998 |
| 1H–13C NMR-based urine metabolic profiling in autism spectrum disorders S Mavel, L Nadal-Desbarats, H Blasco, F Bonnet-Brilhault, C Barthélémy, ... Talanta 114, 95-102, 2013 | 89 | 2013 |
| Carbon‐11 labelling of MADAM in two different positions: a highly selective PET radioligand for the serotonin transporter J Tarkiainen, J Vercouillie, P Emond, J Sandell, J hiltunen, Y Frangin, ... Journal of Labelled Compounds and Radiopharmaceuticals: The Official Journal …, 2001 | 87 | 2001 |
| Synthesis and biological evaluation of a series of flavone derivatives as potential radioligands for imaging the multidrug resistance-associated protein 1 (ABCC1/MRP1) S Mavel, B Dikic, S Palakas, P Emond, I Greguric, AG de Gracia, F Mattner, ... Bioorganic & medicinal chemistry 14 (5), 1599-1607, 2006 | 73 | 2006 |
| Liquid chromatography–high-resolution mass spectrometry-based cell metabolomics: Experimental design, recommendations, and applications BM Hounoum, H Blasco, P Emond, S Mavel TrAC Trends in Analytical Chemistry 75, 118-128, 2016 | 69 | 2016 |
| Pharmacological Characterization ofN, N-Dimethyl-2-(2-amino-4-methylphenyl thio) benzylamine as a Ligand of the Serotonin Transporter with High Affinity and Selectivity S Chalon, J Tarkiainen, L Garreau, H Hall, P Emond, J Vercouillie, ... Journal of Pharmacology and Experimental Therapeutics 304 (1), 81-87, 2003 | 67 | 2003 |
| Wildtype motoneurons, ALS‐Linked SOD1 mutation and glutamate profoundly modify astrocyte metabolism and lactate shuttling B Madji Hounoum, S Mavel, E Coque, F Patin, P Vourc'h, S Marouillat, ... Glia 65 (4), 592-605, 2017 | 66 | 2017 |
| Pharmacological characterization of (E)-N-(3-iodoprop-2-enyl)-2β-carbomethoxy-3β-(4′-methylphenyl) nortropane as a selective and potent inhibitor of the neuronal dopamine … S Chalon, L Garreau, P Emond, L Zimmer, MP Vilar, JC Besnard, ... Journal of Pharmacology and Experimental Therapeutics 291 (2), 648-654, 1999 | 66 | 1999 |
